Pain Management for Osteoarthritis: A 6-question Quiz
Opioids or opiate-like analgesics? Weight loss, exercise, or orthotics? Sleep interventions or cognitive therapy? What works for OA pain and what's the evidence?
COVID-19 Update: US and Global Cases, Deaths, and Recoveries as of February 2, 2021
Global confirmed cases of COVID-19 have surpassed 103 million. We summarize more of today's data from the Johns Hopkins COVID-19 interactive map.
Patients Often Miss Boosters in 2-dose Vaccine Regimens
Patients most often blame forgetfulness for not getting a second shot so reminders are key; just don't rely on a message via a patient portal to reach them.
COVID-19 Update: US and Global Cases, Deaths, and Recoveries as of February 1, 2021
Data from the Johns Hopkins COVID-19 interactive map on coronavirus cases, mortalities, recoveries, and more.
“Normal” Life vs Vaccine Fear: What Americans Want Most
Will desire to return to “normal” life propel patients to get a COVID-19 vaccine? What do they think about efforts to contain transmission? Answers and more insights here.
Brigham & Women's Diabetes Expert Highlights 2020 Research
Director of the Brigham and Women's Diabetes Program Marie McDonnell, MD, talked with our editor about 2020 studies on SGLT-2 inhibitors, insulin icodec, and more.
COVID-19 Update: US and Global Cases, Deaths, and Recoveries as of January 29, 2021
Novavax, J&J Vaccine Candidates Effective Against COVID-19, Variants
Vaccines from both companies were significantly effective against COVID-19 and show promise against variants from the UK and South Africa.
Oral CGRP Inhibitor Rimegepant Effective in Migraine Prevention, Study Finds
In a phase 2/3 study, nearly half of rimegepant-treated patients demonstrated ≥50% reduction in the number of moderate-to-severe migraine days per month
COVID-19: Levels are Decreasing, but CDC Urges Public to Remain Cautious
US levels of SARS-CoV-2 circulation, associated illnesses, and deaths have been decreasing, but rising reporting delays due to holidays warrant caution.
FDA Approves Novel Agent for Treatment of Heart Failure
The FDA approved vericiguat to reduce the risk of CV death and rehospitalization for HF in HF patients after hospital discharge or after outpatient treatment with IV diuretics.
COVID-19 Update: US and Global Cases, Deaths, and Recoveries as of January 28, 2021
Primary Viewpoints Episode 6: COVID-19 Impact on Physician Mental Health
In episode 6 of Primary Viewpoints, physician mental health expert Michael Myers, MD, discusses the state of physician mental health during the COVID-19 pandemic.
Physician Mental Health Expert: Please, Check In with Each Other
The COVID-19 pandemic, says Dr Michael Myers, is an unprecedented environment for practicing medicine and for practitioners to effectively process daily experience.
COVID-19 Vaccine: US Cities in Greatest Immediate Need
Availability of the COVID-19 vaccine cannot come fast enough for many large US cities, based on the share in each of the most vulnerable populations.
COVID-19 Update: US and Global Cases, Deaths, and Recoveries as of January 27, 2021
Global confirmed cases of COVID-19 have surpassed 100 million. We summarize more of today's data from the Johns Hopkins COVID-19 interactive map.
Study: Metabolic Surgery May be Cure for Type 2 Diabetes
Compared to medication and lifestyle changes, metabolic surgery is more effective in the long-term control of severe T2D, a new study found.
COVID-19 Update: US and Global Cases, Deaths, and Recoveries as of January 26, 2021
Exercise Insufficient to Overcome CVD Risks of Overweight/Obesity
Physical activity cannot compensate adequately for the negative impact of excess body weight on cardiometabolic health.
Merck Says it Will Stop Development of COVID-19 Vaccine Candidates
Merck announced today that it will halt development of its COVID-19 vaccine candidates, citing inadequate immune responses to the vaccines.